Jake Leonard

WORK HISTORY

EDUCATION

SKILLS

ABOUT JAKE LEONARD

Intrinsically driven, strategic, self-motivated and spirited leader with extensive accomplishments within pharmaceutical development and process improvement. Enthusiastic professional with a demonstrated history of successful program management, interdepartmental communication, organizational strategy, and effective leadership. Strong ability to manage the drug development process from discovery through IND submission and beyond by integrating risk assessment and organizational resource efficiency into business strategy. Expertise includes timeline strategy, budget forecasting, contract/invoice management, cross-functional system implementation, manufacturing processes, cGMP compliance, among others. Exemplifies emotional prowess to provide stable and effective leadership while conveying a passion for problem solving and team harmonization. Adept at earning high levels of trust across organizations while mastering communication from top down as well as bottom up to emphasize transparent respect at all levels.CAREER HIGHLIGHTS• Successfully managed all IND-enabling studies for lead program, leading to the $1B acquisition of DTx Pharma by Novartis.• Strategically planned and executed all preclinical studies for multiple NDE programs supporting the close of the $6.7B acquisition of Arena Pharmaceuticals by Pfizer. • Deployed tools and systems to drive innovation throughout organizations, leading to less required resources and reduced costs. • Devised and implemented processes to properly forecast the annual budget as well as handle change order tracking for seven-figure line items within a $24M+ department budget. • Managed 3 large programs for the highest revenue client, whose programs required full drug development and manufacturing activities across multiple sites. • Championed a Lean Six Sigma Greenbelt project which implemented an electronic lab notebook system into the department, therefore increasing efficiency while achieving 100% ROI in 2 years.